While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...] …
Category: Federal
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
Less than four days remain for stakeholders to comment on the highly anticipated bipartisan senate draft 340B program overhaul, and [...] …
An influential conservative congressional caucus is urging Congress to significantly cut Medicaid spending and “ to ensure that drug discounts [...] …
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...] …
Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...] …
Unreleased figures show “double digit growth again for the 340B program” in 2023, the leader of the 340B prime vendor [...] …
If House Republicans maintain control of the chamber after the November elections, several senior members will likely vie to chair [...] …
The inclusion of a provision in draft 340B reform legislation creating “user fees” on 340B covered entities (CEs) is likely [...] …
One influential Republican senator criticized 340B and another Republican senator expressed support for the program during today’s much-awaited Senate committee [...] …